bioRxivBiochemistryPreprint
Highly Sensitive and Specific Amyloid-β Oligomers Detection Using CRISPR-Cas12a Probe System aided by Graphene Oxide for Early Diagnosis of Alzheimer's Diseases
Abstract
Alzheimers disease (AD) is highly age-specific that results in cognitive incapability including dementia. It is proposed that AD is caused by the dysfunctional gene producing excessive amyloid-{beta} protein that eventually results in aggregated form of amyloid-{beta} Oligomers (A{beta}O). We couple the CRISPR-Cas12a system with a specially designed single-stranded DNA (ssDNA) aptamer that specifically forms a hybrid complex with A{beta}O. We exploit the aptamer as the substrate for the crRNA-aptamer duplex due to its high flexibility, sensitivity, and selectivity. We further adopted the graphene oxide (GO) fluorescent system to couple with our CRISPR-Cas12a probe system. Our coupled probe system can effectively detect the presence of A{beta}O by quantitatively returning fluorescent signals with high specificity and accuracy.
- assay: proteomics
- research focus: differential expression
- approach: experimental assay
- approach: wet-lab / biochemical assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A genetically encoded selection for amyloid-β oligomer binders
ByungUk Lee, John A. Mannone, Tina Wang·Nature Chemical BiologyPeer-reviewed·Jul 15, 2025
- Advancing Early Diagnosis of Alzheimers Disease: A Paper-Based Aptasensor for Detecting Amyloid Beta(1-42) and p-tau181 from Plasma Using CdTe Quantum Dots
Elif Betül Balcı, Elif Nur Yildiz, … Umut Hasirci·bioRxiv·Jul 10, 2024
- Engineering a Dimeric Single-Domain Antibody for Improved Detection and neutralization of Amyloid-β oligomers
Liliana Napolitano, Devkee M. Vadukul, … Francesco A. Aprile·Communications BiologyPeer-reviewed·Mar 27, 2026
- The therapeutic and diagnostic potential of amyloid β oligomers (AβOs) selective antibodies to treat Alzheimer's disease
Kirsten L. Viola, Maira Assunção Bicca, … William L. Klein·Frontiers in NeurosciencePeer-reviewed·Jan 3, 2022
- Development of amyloid beta gold nanorod aggregates as optoacoustic probes
M. G. Soliman, H. A. Davies, … J. Madine·bioRxiv·Oct 25, 2021
- ThX - A next-generation probe for the early detection of amyloid aggregates
L.-M. Needham, J. Weber, … S. F. Lee·bioRxiv·Jul 24, 2019